IGFBP7 and gastric cancer: Furthermore, the suppression of IGFBP7 expression has been demonstrated to impede GC cell proliferation and invasiveness in both in vitro and in vivo models, underscoring the potential of IGFBP7 as a therapeutic target in gastric cancer treatment (61).